← back to search

Shaoqing Ju

Hebei Medical University · CN
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer-related molecular mechanisms research, RNA modifications and cancer, Cancer Genomics and Diagnostics, and Circular RNAs in diseases.
h-index
16
citations
766
works
41
NIH funding
primary concept
email

Recent publications

Causal insights into major risk factors for diabetic kidney disease: a comprehensive meta-analysis and Mendelian randomization study
Renal Failure 2025cited by 8position: middledoi
Comprehensive assessment of serum 3′-tRFArg as a novel diagnostic biomarker for gastric cancer
Translational Oncology 2025cited by 2position: lastdoi
Ferroptosis in tumors and its relationship to other programmed cell death: role of non-coding RNAs
Journal of Translational Medicine 2023cited by 35position: lastdoi
Serum tRF-27-FDXXE6XRK45 as a Promising Biomarker for the Clinical Diagnosis in Gastric Cancer
International Journal of Medical Sciences 2023cited by 11position: lastdoi
YY1-induced LncRNA-TUG1 elevates YOD1 to promote cell proliferation and inhibit bortezomib sensitivity in multiple myeloma
Leukemia & lymphoma/Leukemia and lymphoma 2023cited by 5position: lastdoi
LncRNA HCP5 : A Potential Biomarker for Diagnosing Gastric Cancer
Frontiers in Oncology 2021cited by 31position: lastdoi
Circulating lncRNA DANCR as a potential auxillary biomarker for the diagnosis and prognostic prediction of colorectal cancer
Bioscience Reports 2020cited by 40position: lastdoi
Long non-coding RNA CCAT2 as a potential serum biomarker for diagnosis and prognosis of multiple myeloma
Annals of Hematology 2020cited by 15position: lastdoi
Serum Level of Long Noncoding RNA B3GALT5-AS1 as a Diagnostic Biomarker of Colorectal Cancer
Future Oncology 2020cited by 13position: middledoi
Decreased expression of IGFBP6 correlates with poor survival in colorectal cancer patients
Pathology - Research and Practice 2020cited by 12position: middledoi
Knockdown of long non-coding RNA PCAT-1 inhibits myeloma cell growth and drug resistance via p38 and JNK MAPK pathways
Journal of Cancer 2019cited by 41position: lastdoi
Copy number variations primed lncRNAs deregulation contribute to poor prognosis in colorectal cancer
Aging 2019cited by 40position: middledoi
Elevated serum lncRNA TUG1 levels are a potential diagnostic biomarker of multiple myeloma
Experimental Hematology 2019cited by 37position: lastdoi
Circulatinglong non-coding RNA FEZF1-AS1 and AFAP1-AS1 serve as potential diagnostic biomarkers for gastric cancer
Pathology - Research and Practice 2019cited by 21position: lastdoi
<i>Retracted:</i> Decreased expression of long noncoding RNA XLOC_013703 promotes cell growth via NF‐κB pathway in multiple myeloma
IUBMB Life 2019cited by 15position: lastdoi
Diagnostic Value of Serum Concentration and Integrity of Circulating Cell-Free DNA in Breast Cancer: A Comparative Study With CEA and CA15-3
Laboratory Medicine 2018cited by 57position: middledoi
Long non-coding RNA CCAL/miR-149/FOXM1 axis promotes metastasis in gastric cancer
Cell Death and Disease 2018cited by 32position: lastdoi
Regulatory effects of lncRNAs and miRNAs on autophagy in malignant tumorigenesis
Bioscience Reports 2018cited by 28position: lastdoi
Upregulated lncRNA-PCAT1 is closely related to clinical diagnosis of multiple myeloma as a predictive biomarker in serum
Cancer Biomarkers 2017cited by 77position: lastdoi
Alu-based cell-free DNA: a novel biomarker for screening of gastric cancer
Oncotarget 2016cited by 56position: middledoi
Plasma miR-185 is decreased in patients with esophageal squamous cell carcinoma and might suppress tumor migration and invasion by targeting RAGE
American Journal of Physiology-Gastrointestinal and Liver Physiology 2015cited by 23position: middledoi
Effects of histone deacetylase inhibition on the survival, proliferation and migration of Schwann cells, as well as on the expression of neurotrophic factors and genes associated with myelination
International Journal of Molecular Medicine 2014cited by 15position: middledoi
Cell-Free Circulating DNA: A New Biomarker for the Acute Coronary Syndrome
Cardiology 2013cited by 65position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Xianjuan Shen · Nantong University11 papers (2016–2025)Hui Cong · Nantong University7 papers (2015–2020)Qingqing Yin · Nantong University5 papers (2018–2023)Xudong Wang · Tianjin Medical University Cancer Institute and Hospital5 papers (2017–2020)Xinhua Wu · Kunming University of Science and Technology3 papers (2013–2017)Rongrong Jing · Nantong University3 papers (2013–2016)Guihua Wang · Shandong Agricultural University3 papers (2018–2020)Honglei Xu · Ningbo University2 papers (2020–2023)Lurong Zhang · University of Florida2 papers (2013–2016)Jing Qi · Shandong University2 papers (2016–2017)Xiaopeng Cui · Nantong University2 papers (2019–2020)Xun Li · Nantong University2 papers (2023–2025)Ming Cui · Nantong University2 papers (2013–2015)Xinliang Gu · Nantong University2 papers (2023–2025)Feng Wei · Hebei Medical University2 papers (2018–2020)Feng Wang · Nantong Tumor Hospital2 papers (2019–2019)Xudong Wang · Nantong University1 papers (2020–2020)Xian Li · Weifang Medical University1 papers (2023–2023)Weihua Cai · Nantong University1 papers (2019–2019)Xiaoyu Gu · Nanjing University of Chinese Medicine1 papers (2019–2019)